TORONTO (PRWEB) October 05, 2021 —Microfluidics technology is a vital component of diagnostic testing and microfluidics manufacturer, uFluidix, is at the forefront of the industry. Following a major expansion in 2020 which saw the company double manufacturing capacity, uFluidix marks 2021 with continued growth and...
"Low-temperature biopreservation and 3D tissue engineering present two different routes towards eventual on-demand access to transplantable biologics, but recent advances in both fields present critical new opportunities for crossover between them. With help of microfluidics, in this work, we demonstrate sub-zero centigrade preservation and revival...
Myocardial infarction, commonly known as heart attack, causes a majority of cardiovascular disease (CVD) deaths which can be triggered by occlusion of the arteries. Finding new drugs to fight myocardial infractions requires accurate modelling of the process. In a recent article published in the lab...
"Droplets microfluidics is broadening the range of Lab on a Chip solutions that, however, still suffer from the lack of an adequate level of integration of optical detection and sensors. In fact, droplets are currently monitored by imaging techniques, mostly limited by time-consuming data post-processing...
Since its emergence as a model organism, Caenorhabditis elegans (C. elegans), has appeared as a powerful means for studying a broad range of topics ranging from developmental biology to neuroscience. Having many genes with functional counterparts in humans, a transparent body, a short life cycle...